ScholarIQanswers from OpenAlex
Clinical Cancer Research
JournalCitation impact & published research
Clinical Cancer Research is a journal indexed in ScholarIQ from OpenAlex.
How many works does Clinical Cancer Research have?
ScholarIQindexed works
Clinical Cancer Research has 27,687 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Clinical Cancer Research have?
ScholarIQcitation count
Clinical Cancer Research has 1,646,710 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Clinical Cancer Research?
ScholarIQh-index
Clinical Cancer Research has an h-index of 421 in OpenAlex.
What is the OpenAlex record for Clinical Cancer Research?
ScholarIQopenalex
The OpenAlex for Clinical Cancer Research is on the source record.
What are the most-cited papers on Clinical Cancer Research?
ScholarIQmost cited works
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
Torsten O. Nielsen, Forrest D. Hsu, Kristin C. Jensen, Maggie C.U. Cheang, Gamze Karaca, Zhiyuan Hu, Tina Hernandez‐Boussard, Chad Livasy, Dave Cowan, Lynn G. Dressler, Lars A. Akslen, Joseph Ragaz, Allen M. Gown, C. Blake Gilks, Matt van de Rijn, Charles M. Perou
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with <i>EGFR</i> -Mutant Lung Cancers
Helena A. Yu, Maria E. Arcila, Natasha Rekhtman, Camelia S. Sima, Maureen F. Zakowski, William Pao, Mark G. Kris, Vincent A. Miller, Marc Ladanyi, Gregory J. Riely
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg, James Chih‐Hsin Yang, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Giao Q. Phan, Deborah E. Citrin, Nicholas P. Restifo, Paul F. Robbins, John R. Wunderlich, Kathleen E. Morton, Carolyn M. Laurençot, Seth M. Steinberg, Donald E. White, Mark E. Dudley
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
Lisa A. Carey, Elizabeth Claire Dees, Lynda Sawyer, Lisa Gatti, Dominic T. Moore, Frances A. Collichio, David W. Ollila, Carolyn I. Sartor, Mark L. Graham, Charles M. Perou
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis
Justin F. Gainor, Alice T. Shaw, Lecia V. Sequist, Xiujun Fu, Christopher G. Azzoli, Zofia Piotrowska, Tiffany G. Huynh, Ling Zhao, Linnea Fulton, Katherine R. Schultz, Emily Howe, Anna F. Farago, Ryan J. Sullivan, James R. Stone, Subba R. Digumarthy, Teresa Morán, Aaron N. Hata, Yukako Yagi, Beow Y. Yeap, Jeffrey A. Engelman, Mari Mino–Kenudson